📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy. (2013)

First Author: Mitrpant C

Attributed to: MICA: MRC Centre for Neuromuscular Diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0062114

PubMed Identifier: 23630626

Publication URI: http://europepmc.org/abstract/MED/23630626

Type: Journal Article/Review

Volume: 8

Parent Publication: PloS one

Issue: 4

ISSN: 1932-6203